There WAS a 4.7% fall in GlaxoSmithKline shares yesterday as the pharma giant warned on earnings.
The firm, which has a major manufacturing site at Montrose, revealed a 22% drop in core operating profits to £2.94 billion in the first six months of the year.
The company said it had been impacted by the stronger pound.
It also revealed a 19% second-quarter fall in demand for Advair, its best-selling drug in the US.
GSK, which is facing a bribery probe in China, is hoping that a complex transaction with rival Novartis will boost its fortunes through the creation of a £6.5bn consumer healthcare business.
